AMCP Advisory Board
ADVI was tasked with helping a client identify the optimal value proposition and market access options that would maximize the pricing and reimbursement potential of a new compound.
ADVI was tasked with helping a client identify the optimal value proposition and market access options that would maximize the pricing and reimbursement potential of a new compound. We designed, planned, executed and moderated two payer workshops in conjunction with AMCP annual meetings. This helped the client: design marketing and clinical trial strategies to deliver data to support drug value; understand reimbursement acceptance of the target product profile, given evolution of indications and restrictive payer policies; and identify appropriate clinical and pharmacoeconomic endpoints designed to optimize both speed and likelihood of reimbursement/formulary listing.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.